Tuberous sclerosis complex (TSC) is a genetic disease with an incidence between 1 in 6,000 and 1 in 11,000 births presenting with multiple neurological symptoms including epilepsy, mental retardation and autism. Jackelien van Scheppingen investigates the molecular mechanisms of pathology in TSC in order to find potential targets and novel therapeutic strategies. Additionally, she aims to evaluate possible functional modulations of inflammatory pathways using in vitro astrocyte cultures.
J.G.M. van Scheppingen: Astrocytes as Mediators of Inflammation in Epilepsy: Focus on Tuberous Sclerosis Complex.
Prof. E.M.A. Aronica
Dr E.A. van Vliet
This event is open to the public.